Younger females are at greater risk of vasodilation-related adverse symptoms caused by dihydropyridine calcium channel blockers: results of a study of 11,918 Japanese patients.

@article{Kajiwara2014YoungerFA,
  title={Younger females are at greater risk of vasodilation-related adverse symptoms caused by dihydropyridine calcium channel blockers: results of a study of 11,918 Japanese patients.},
  author={Ayami Kajiwara and Junji Saruwatari and Ayana Kita and Kentaro Oniki and Masato Yamamura and Motoji Murase and Haruo Koda and Seisuke Hirota and Tadao Ishizuka and K Nakagawa},
  journal={Clinical drug investigation},
  year={2014},
  volume={34 6},
  pages={431-5}
}
BACKGROUND AND OBJECTIVE Adequate control of blood pressure in younger females is of crucial importance, because they are at higher risk of hypertensive target organ damage compared with males of similar age. In addition, female sex is a risk factor for adverse effects of antihypertensive drugs, especially dihydropyridines. This study set out to assess the incidence of adverse reactions during dihydropyridine use in a real-life clinical setting, focusing on the influence of female sex and age… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 17 references

Similar Papers

Loading similar papers…